![Immunosuppressants / Carfilzomib / Epoxides / Morpholines / Bortezomib / Proteasome inhibitor / Lenalidomide / Multiple myeloma / Onyx Pharmaceuticals / Chemistry / Medicine / Organic chemistry Immunosuppressants / Carfilzomib / Epoxides / Morpholines / Bortezomib / Proteasome inhibitor / Lenalidomide / Multiple myeloma / Onyx Pharmaceuticals / Chemistry / Medicine / Organic chemistry](https://www.pdfsearch.io/img/31fe1e6560603cec868df64337f2231c.jpg)
| Open Document File Size: 148,84 KBShare Result on Facebook
Company Onyx Pharmaceuticals / Application Applicant Onyx Pharmaceuticals / / Event FDA Phase / / MedicalCondition Multiple Myeloma / disease / relapsed disease / refractory multiple myeloma / / Organization FDA / Oncologic Drugs Advisory Committee / / Person Haleh Saber / Christine Garnett / Todd Palmby / Jeffrey Bray / Julie Bullock Christine / Thomas Herndon / Josephine Jee / Janice Brown / Nicole Gormley Albert Deisseroth / Koti Mark Rothmann / Jessica Hawes / Karen Bengtson Janet Jamison / Angelica Dorantes / William Adams / Bryan Riley / John Metcalfe / Anthony Orencia Susan / / Position Medical Officer / Reviewer Team Leader / Leibenhaut Project Manager / / Product Orencia / prednisone / Cyclophosphamide / Kyprolis™ / MM Regular Alkylating Agent / / Technology transplantation / /
SocialTag |